Author Question: A 27-year-old woman received from the emergency department is on a nasal cannula at 5 L/min. ... (Read 75 times)

misspop

  • Hero Member
  • *****
  • Posts: 540
A 27-year-old woman received from the emergency department is on a nasal cannula at 5 L/min. Approximately what FiO2 is this patient receiving?
 
  a. 28
  b. 32
  c. 35
  d. 40

Question 2

Which of the following factors should be used in properly selecting an O2 delivery device?
 
  1. Knowledge of general performance of the device
  2. Physician's preference
  3. Individual capabilities of the equipment
  a. 2 and 3 only
  b. 1 and 2 only
  c. 1, 2, and 3
  d. 1 and 3 only



huda

  • Sr. Member
  • ****
  • Posts: 304
Answer to Question 1

ANS: D
Estimating the FiO2 provided by low-flow systems: For patients with a normal rate and depth of breathing, each liter per minute of nasal O2 increases the FiO2 approximately 4. For example, a patient using a nasal cannula at 4 L/min has an estimated FiO2 of approximately 37 (21 + 16).

Answer to Question 2

ANS: D
Proper device selection requires in-depth knowledge of both the general performance characteris-tics of these systems and the individual capabilities.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Aspirin is the most widely used drug in the world. It has even been recognized as such by the Guinness Book of World Records.

Did you know?

Walt Disney helped combat malaria by making an animated film in 1943 called The Winged Scourge. This short film starred the seven dwarfs and taught children that mosquitos transmit malaria, which is a very bad disease. It advocated the killing of mosquitos to stop the disease.

Did you know?

The toxic levels for lithium carbonate are close to the therapeutic levels. Signs of toxicity include fine hand tremor, polyuria, mild thirst, nausea, general discomfort, diarrhea, vomiting, drowsiness, muscular weakness, lack of coordination, ataxia, giddiness, tinnitus, and blurred vision.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library